2023 ESG Report
Our mission, to protect and enhance life, calls us to create a culture where the quality of our products and the wellbeing of our patients and employees are paramount. We strive to deliver on our high standards daily, and where we fall short, we identify and take action to address the issue. We do this because it is core to who we are.
In our fourth annual ESG Report, we outline the progress we made in 2023. We also turn our eyes to the future for Emergent, our people, our partners, our neighbors and our customers.
“In 2023, Emergent’s 25th year as a leader in public health preparedness, we continued to deliver on our commitments to the U.S. government and other customers around the world to address public health threats. At our core, we remain committed to our mission and what we aim to achieve in the next 25 years.” — Joseph Papa, President and Chief Executive Officer
ESG Priority Issues
- Access to medicine
- Community engagement
- Compliance
- Corporate governance
- Diversity, equity, and inclusion
- Employee engagement
- Environmental, health, and employee safety
- Governmental relationships
- Manufacturing and product quality
- Patient and drug safety
- Scientific integrity
- Supply chain management